Q2i empowers healthcare teams with leading edge technology to improve the success of their Medication-Assisted Treatment (MAT) program.

Q2i’s solutions comprise healthcare team portals and patient mobile applications. We provide decision support software through data-rich, patient-centric, unified dashboards. Our technology includes predictive analytics (including AI and ML), telehealth and reward based solutions that increase patient engagement, adherence to treatment plans, connectedness and support, resulting in:

  • Focus on at-risk patients
    Outliers identified and patients managed by exception
  • Timely interventions
    Trending issues immediately flagged for attention
  • Better outcomes
    Improved ownership and adherence to treatment plans

100% Cloud, ready-to-go

Start using Q2i to support your program in minutes – easily setup and manage your clinic and patients.


Modern User Interface

The Q2i healthcare team portal and patient app interface is intuitive and easy to navigate for an unequalled user experience.

Customizable Branding

Q2i customizable branding allows you to integrate Q2i into your digital tool box and keeps your branding message consistent.


Flexible and Scalable

Q2i can be used as a stand alone program management solution or easily integrated with your existing EHR.

HIPAA Compliant

Q2i is proud to be HIPAA compliant. All data policies are designed to meet or exceed HIPAA’s requirements.


Opioid Addiction Recovery Support is used by providers of MAT programs to improve insight into a patient’s recovery progress and promotes ownership and adherence to treatment plans. OARS also provides extensive tools to support patients with recovery from Opioid Use Disorder. Using OARS patients are better connected to, and supported by their healthcare team throughout their recovery journey.

This extended connection and support fosters conditions for:

  • Adherence to treatment plans
  • Fewer relapses
  • Less overdose incidents
  • Decreased in-patient admissions/ re-admissions
  • Reduced program dropouts
  • Reduced ER visits

Continuing Alumni Support Application provides ongoing connection and support to patients who have completed a residential or Intensive Out Patient recovery program.

CASA enables providers to regularly deliver educational and motivational content including reinforcement of relapse prevention strategies direct to the CASA powered mobile app.

The peer-to-peer messaging component helps build and maintain a network of sober friends with other alumni of the clinic and stay connected to others who relate to similar experiences and challenges.

The Bari-Well solution supports bariatric healthcare teams and their patients by enhancing a bariatric program’s connectivity, efficiency and success.

Bari-Well empowers bariatric programs to better manage their patient populations. Bari-Well supports patients with pre and post surgery treatment plans in order to successfully achieve goals of long-term weight-loss.

Bari-Well provides useful tools to help providers manage and support their patients throughout all stages of the continuum of care.

About Q2i


To design, develop, and supply the most advanced technologies that empower healthcare teams to improve the success rate of their Medication-Assisted Treatment (MAT) programs.


To drive innovation, thereby increasing MAT program availability and access so that all Americans seeking recovery from Opioid Use Disorder can obtain the treatment they need.


Q2i collaborates with multidisciplinary healthcare teams, providers and payers to understand and then realize unmet technology needs. We facilitate improvements in patient care by supporting patients with their treatment plans through better connection and information exchange with their healthcare teams.

Q2i develops technology that assists health care providers in achieving the IHI quadruple aim of improving the patient experience of care (including quality and satisfaction), improving the health of populations, reducing the per capita cost of health care and improved clinician experience.

Leadership Team

Steven Jenkins

Steven Jenkins


Steven Jenkins has over 20 years of senior management experience in the technology and HealthTech sectors in North America and Europe. Prior to founding Q2i, he worked for 10 years on medical technologies (devices and software applications) that aided pediatric pain and anxiety management and improved home dialysis. He is focused on launching medical technologies that improve patient outcomes and reduce clinical costs.


Gerald A. Kraines, M.D.

Gerald A. Kraines, M.D.


Gerald A. Kraines, M.D. a faculty member at Harvard Medical School for over 30 years, Dr. Kraines received an undergraduate degree from Oberlin College in organic chemistry, a medical degree from Case Western Reserve, and a psychiatric fellowship and a postgraduate degree in community psychiatry from HarvardMedical School. Dr. Kraines has undertaken several public health projects in the United States, including two years in the U.S. Public Health Service.

Tony McNamara

Tony McNamara


Tony McNamara has over 15 years of experience driving innovation in medical technology companies. He was involved in the first wave of Electronic Medical Record and of Case Management Systems, including both ConnectMD and Phycom’s CarePartner. His experience with medical devices includes portable ultrasound (BladderScanner), tele-medicine-enabled video (laryngoscope),and carrying the Olympic Medical Cerebral Function Monitor from mid-stream to completion.

Monica Strunk

Monica Strunk

Director, Grants and Strategic Partnerships

Monica has over 20 years of experience in fundraising, strategic planning, managing strategic partnerships, and coordinating fundraising programs. Her focusis on grants administration (pre-award development and post-award compliance), supporting organizations with the development and submission of federal, foundation and industry-sponsored grant proposals.

Medical Advisory Board

Q2i’s Medical Advisory Board provides in-depth subject matter expertise across a broad spectrum of healthcare delivery. This diverse composition provides a strong group dynamic providing insight and scientific direction. This ensures Q2i’s solutions not only improves patient outcomes and helps health systems and payers create value but that we go beyond traditional clinical efficacy to capture newer patient-focused considerations and impact the effectiveness and efficiency of care delivered under new value-based performance systems.

Sara M. Bolton

Sara M. Bolton


Dr. Bolton is an assistant clinical professor of psychiatry at Harvard Medical School and an associate psychiatrist at McLean Hospital.

More »

Gary Chinman

Gary Chinman


Dr. Chinman is assistant professor of psychiatry at Harvard Medical School and president-elect of the Massachusetts Psychiatric Society.

More »

Guy Slater

Guy Slater


Guy is a consultant surgeon specializing in laparoscopic gastro-intestinal surgery and weight loss surgery.

More »

Jeremy Vigneault

Jeremy Vigneault


Jeremy is a faculty member in the Department of Kinesiology and is the Director of the Nayden Rehabilitation Clinic.

More »

Jennifer Davenport

Jennifer Davenport


Dr. Jennifer Davenport is a Medical Director and Director of Interventional Cardiology. She has a Masters in Health Systems Administration and Policy.

More »

P. Elizabeth Thomas

P. Elizabeth Thomas


Dr. Thomas is board certified by the American Board of Pediatrics and the American Board of Pediatric Cardiology.

More »

Q2i in the News

Jan 8, 2018

Q2i Adds Telehealth Capabilities to Its Solutions, Improving Availability and Access to Recovery from Opioid Addiction

Read more ›

Nov 15, 2018

Q2i’s Outcome-Measures Software Helping Improve Quality of Treatment for Substance Use Disorder

Read more ›

Oct 9, 2018

Q2i’s New MATRA Technology Enables Earliest Interventions to Improve Recovery from Opioid Use Disorder

Read more ›

Sep 20, 2018

Harbor Homes becomes first healthcare organization in New Hampshire to utilize OARS technology to improve treatment for opioid use disorder

Read more ›

Sep 6, 2018

Maine-Based Door to Door Doctors Deploys Q2i’s OARS Technology to Support Patients Recovering from Opioid Use Disorder

Read more ›

April 24, 2018

The PILLARS Recovery Center Deploys Q2i’s CASA Technology To Better Support People In Recovery from Substance Abuse
Read more ›

Mar 22, 2018

Alyssa’s Place: Peer Recovery Center Deploys Q2i’s CASA Technology to Improve After-Treatment Care of Substance Use Disorder Patients.
Read more ›

Mar 8, 2018

Q2i Partners with athenahealth’s ‘More Disruption Please’ Program to Enable Providers to Gain Insight into OUD Patients’ Recovery Progress and Improve Patient Outcomes.
Read more ›

Jan 16, 2018

Q2i launches CASA, technology supporting residential and outpatient recovery clinics with their after treatment programs.
Read more ›

Dec 29, 2017

Q2i launches Bari-Well, technology supporting bariatric programs and patients with long-term weight loss.
Read more ›

August 24, 2017

Technology proving successful in supporting fight against opioid epidemic – Q2i announce that Heywood Medical Group is utilizing its Opioid Addiction Recovery Support (OARS) software to support patients with addiction recovery.
Read more ›

July 18, 2017

Using Technology to Battle the Opioid Epidemic – Health Tech Company, Q2i, Launches its Innovative behavioral healthcare management software, OARS.
Read more ›

Please check back with us for upcoming events and conference details or contact us.

Contact Q2i

(P) 617.606.3113
1660 Soldiers Field Rd.
Brighton, MA 02135